PX trades 231.1% below Wall Street's consensus target of $25.00.
Last 12 months price action with 12-month analyst target path
The base valuation assumes PX achieves its forward estimates and maintains a stable P/E multiple of 6.9x. This scenario reflects the blended consensus of 8 Wall Street analysts, balancing both positive catalysts and macroeconomic headwinds over the next 12 months.
As of June 23, 2026, P10, Inc. (PX) has a Wall Street consensus price target of $25.00, based on estimates from 8 covering analysts. With the stock currently trading at $7.55, this represents a potential upside of +231.1%. The company has a market capitalization of $909M.
Analyst price targets range from a low of $25.00 to a high of $25.00, representing a 0% spread in expectations. The median target of $25.00 aligns closely with the consensus average. The tight target dispersion indicates high conviction among analysts.
The current analyst consensus rating is Buy, with 4 analysts rating the stock as a Buy or Strong Buy,3 rating it Hold, and 1 rating it Sell or Strong Sell. The positive sentiment balance indicates moderate optimism about the stock prospects.
From a valuation perspective, PX trades at a trailing P/E of 47.2x and forward P/E of 6.9x. The forward PEG ratio of 0.05 suggests the stock may be undervalued relative to its growth. Analysts expect EPS to grow -91.8% over the next year.
Our proprietary valuation model, which blends historical multiples with forward estimates, suggests a base-case price target of $464.70, with bear and bull scenarios of $292.76 and $612.28 respectively. Model confidence stands at 47/100, suggesting limited visibility into future performance.
| Company | Market Cap | Price | Target | Upside Potential | Rating | Fwd P/E | Analysts |
|---|---|---|---|---|---|---|---|
AMGAffiliated Managers Group, Inc. | $9.5B | $357.31 | $402.50 | +14.1% | Buy | 10.1x | 12 |
STEPStepStone Group Inc. | $5.7B | $45.46 | $66.80 | +47.8% | Buy | 21.6x | 8 |
HLNEHamilton Lane Incorporated | $4.4B | $79.51 | $144.00 | +75.1% | Buy | 13.6x | 10 |
GCMGGCM Grosvenor Inc. | $2.3B | $12.13 | $18.00 | +49.4% | Buy | 14.0x | 8 |
ARESAres Management Corporation | $41.3B | $125.90 | $171.13 | +32.3% | Buy | 21.5x | 22 |
BXBlackstone Inc. | $96.6B | $123.31 | $156.29 | +26.3% | Buy | 21.0x | 29 |
KKRKKR & Co. Inc. | $86.4B | $96.90 | $141.14 | +45.5% | Buy | 16.1x | 27 |
APOApollo Global Management, Inc. | $78.0B | $135.21 | $153.50 | +11.6% | Buy | 15.4x | 28 |
CGThe Carlyle Group Inc. | $16.1B | $44.57 | $61.00 | +36.2% | Buy | 11.1x | 25 |
TPGTPG Inc. | $15.8B | $41.19 | $59.88 | +42.4% | Buy | 14.9x | 17 |
Quick answers to the most common questions about buying PX stock.
The consensus Wall Street price target for PX is $25, representing 231.1% upside from the current price of $7.55. With 8 analysts covering the stock, this strong upside suggests significant value not yet reflected in today's share price.
PX has a consensus rating of "Buy" based on 8 Wall Street analysts. The rating breakdown is mixed, with 3 Hold ratings making up the largest segment. The consensus 12-month price target of $25 implies 231.1% upside from current levels.
With a forward P/E of 6.9247x, PX trades at a relatively low valuation. The consensus target of $25 implies 231.1% appreciation, suggesting meaningful undervaluation.
The most bullish Wall Street analyst has a price target of $25 for PX, while the most conservative target is $25. The consensus of $25 represents the median expectation. Our quantitative valuation model projects a bull case target of $612 based on optimistic growth and margin assumptions. These targets typically reflect 12-month expectations.
PX is moderately covered, with 8 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 4 have Buy ratings, 3 recommend Hold, and 1 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
The 12-month PX stock forecast based on 8 Wall Street analysts shows a consensus price target of $25, with estimates ranging from $25 (bear case) to $25 (bull case). The median consensus rating is "Buy". Our proprietary valuation model produces a base case fair value of $465, with bear/bull scenarios of $293/$612.
Our quantitative valuation model calculates PX's fair value at $465 (base case), with a bear case of $293 and bull case of $612. The model uses discounted cash flow analysis, historical growth rates, and margin mean-reversion to project FY+2 earnings, then applies an appropriate P/E multiple. The model confidence score is 47/100.
PX trades at a forward P/E ratio of 6.9x based on next-twelve-months earnings estimates compared to a trailing P/E of 47.2x. The lower forward P/E indicates analysts expect earnings growth. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.
Wall Street analysts are very optimistic on PX, with a "Buy" consensus rating and $25 price target (231.1% upside). 4 of 8 analysts rate it Buy or Strong Buy. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
PX analyst price targets range from $25 to $25, a 0% tight range reflecting strong analyst consensus. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $25 consensus represents the middle ground. Our model's $293-$612 range provides an independent fundamental perspective.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
See how regular investing compounds over time.
Compare growth, multiples, and margins vs sector.